Loading...
Loading...
CDC PLACES (2023, crude) estimates 15.5% of adults in Miami have diagnosed diabetes — 3.5 points above the U.S. 12% figure. Census population 442,241. Florida Medicare wound biologics: First Coast Service Options (JN). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Miami clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Miami storefront.
Your Regenerative Medicine Clinic Partner in Miami, FL for clinics & physicians. Partner with Hawk Medical… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Miami is JN (First Coast Service Options) and that adult diabetes here is 15.5% (PLACES 2023), it is selling units, not a program. That is the regenerative medicine clinic conversation we actually have.
National Your Regenerative Medicine Clinic Partner notes (how the product actually works)Florida shares JN with no other states. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 15.5% of adults in Miami have diagnosed diabetes — 3.5 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 15.5% of adults in Miami have diagnosed diabetes — 3.5 points above the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the regenerative medicine clinic account.
CDC PLACES (2023, crude prevalence) estimates 15.5% of adults — 3.5 points above the U.S. 12% figure. Obesity is 29.9%; arthritis is 20%. That is place-level BRFSS modeling, not a clinic census and not a Miami trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Florida.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Florida compliance risk.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Bring specialty, monthly joint / regenerative volume, and whether you bill JN FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 15.5% diabetes and 20% arthritis for Miami — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Miami, FL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Miami is JN geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Miami — 3.5 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Florida Part B wound biologics follow this contractor (siblings: no other states). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Miami. Useful for joint-program math; still needs a diagnosis and privileging.
No Miami storefront. Joe Bradley is an active practice owner. regenerative medicine clinic stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.